Company intelligence / Profile preview

DiagnaMed Holdings

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

DiagnaMed has developed prototypes of its BrainYear (EEG-based brain age estimation) and BrainTremor (wearable EEG device for tremor/brain health monitoring) products. The company is iterating towards commercialization via research collaborations with academic centers. No peer-reviewed, pivotal clinical trial results or regulatory approvals are disclosed as of late 2025.

Therapeutic areas: Neurology
Modalities: DeviceSoftwarePrescription digital therapeutic
Industry: Digital Health Medical Devices

Partnerships

Drexel University (intellectual property license and sponsored research)University Health Network (UHN) (sponsored research on BrainTremor)Regents of the University of Colorado (license for wearable electronics IP)

Beyond the preview

Go deeper on DiagnaMed Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DiagnaMed Holdings.

Explore the full profile